EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges

Xing Cheng, Shaoyi Fan, Chengcai Wen, Xianfa Du

Briefings in Functional Genomics · 20.05.2020 · 19 (3) · 209-214

DOI: 10.1093/bfgp/elaa001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Functional Genomics, online erschienen am 12.02.2020. Verfasst von Xing Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clustered regularly interspaced short palindromic repeats (CRISPR) is described as RNA mediated adaptive immune system defense, which is naturally found in bacteria and archaea. CRISPR-Cas9 has shown great promise for cancer treatment in cancer immunotherapy, manipulation of cancer genome and epigenome and elimination or inactivation of carcinogenic viral infections. However, many challenges remain to be addressed to increase its efficacy, including off-target effects, editing efficiency, fitness of edited cells, immune response and delivery methods. Here, we explain CRISPR-Cas classification and its general function mechanism for gene editing. Then, we summarize these preclinical CRISPR-Cas9-based therapeutic strategies against cancer. Moreover, the challenges and improvements of CRISPR-Cas9 clinical applications will be discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsGenetic TherapyHumansNeoplasms

Stichwörter der Autor:innen

CRISPR/Cas9applicationcancer treatmentchallengetechnology

Autor:innen und Institutionen

  • Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine,Guangzhou, China.
  • Department of Rehabilitation, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
  • Department of Orthopaedics, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Zitieren

APA

Cheng, X., Fan, S., Wen, C., & Du, X. (2020). CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges. Briefings in Functional Genomics, 19(3), 209-214. https://doi.org/10.1093/bfgp/elaa001

Vancouver

Cheng X, Fan S, Wen C, Du X. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges. Briefings in Functional Genomics. 2020;19(3):209-214. doi:10.1093/bfgp/elaa001

BibTeX
@article{Cheng2020,
  author = {Cheng, Xing and Fan, Shaoyi and Wen, Chengcai and Du, Xianfa},
  title = {CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges},
  journal = {Briefings in Functional Genomics},
  year = {2020},
  volume = {19},
  number = {3},
  pages = {209--214},
  doi = {10.1093/bfgp/elaa001}
}
Kostenlos starten →